Skip to main navigation Skip to search Skip to main content

Corrigendum to “Eliminating the tigecycline resistance RND efflux pump gene cluster tmexCD-toprJ in bacteria using CRISPR/Cas9” [International Journal of Antimicrobial Agents 65 (2025) 107390]

  • Lei Xu
  • , Xiaoyu Lu
  • , Yan Li
  • , Patrick Butaye
  • , Shangshang Qin
  • , Zhiqiang Wang*
  • , Ruichao Li*
  • *Corresponding author for this work

Research output: Journal Publications and Reviews › Erratum

Abstract

The authors regret that the sgRNA-F and sgRNA-R sequences in Table 3 were reported as 5′-tagtGTGGTGACGAAAGCACTCAG-3′ and 5′-aaacCTGAGTGCTTTCGTCACCAC-3′, respectively. These oligonucleotides correspond to a tmexD1-targeting candidate evaluated only in preliminary comparisons of targeting efficiency and were not used in the subsequent experiments reported in the article. The correct sequences for the tmexC1-targeting sgRNA used in the reported experiments, as described in Section 2.2, are:

 sgRNA-F: 5′-tagtGGGCTTGTCGCAGCCAACCA-3′ 

sgRNA-R: 5′-aaacTGGTTGGCTGCGACAAGCCC-3′ 

This correction is limited to the sgRNA-F and sgRNA-R sequence entries in Table 3 and does not affect the reported experimental results or conclusions. 

The authors would like to apologise for any inconvenience caused.

© 2026 Elsevier Ltd and International Society of Chemotherapy.

Original languageEnglish
Article number108017
JournalInternational Journal of Antimicrobial Agents
DOIs
Publication statusOnline published - 15 Oct 2026

Fingerprint

Dive into the research topics of 'Corrigendum to “Eliminating the tigecycline resistance RND efflux pump gene cluster tmexCD-toprJ in bacteria using CRISPR/Cas9” [International Journal of Antimicrobial Agents 65 (2025) 107390]'. Together they form a unique fingerprint.

Cite this